Advertisement
News
Advertisement

Thermo Fisher to buy diagnostics firm Phadia for $3.5B

Thu, 05/19/2011 - 5:35am
Mass High Tech: The Journal of New England Technology

Thermo Fisher Scientific Inc. (NYSE: TMO) has entered into a deal to buy Swedish diagnostics firm Phadia AB from a European private equity firm for $3.5 billion. The transaction is expected to close in the fourth quarter of 2011.

Phadia specializes in developing, manufacturing and marketing diagnostic blood test systems in the allergy and autoimmune disease space. Phadia had 2010 total sales of $525 million and has a worldwide head count of 1,500.

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading